Neuroscience News

Inhibiting the firing of nerve cells in a brain area long known to guide goal-directed behavior makes mice build nests and fall asleep, a new study shows. Stimulating the circuit roused the mice and kept them awake.

The study is designed to collect neurophysiological and psychological information from women faced with a breast cancer diagnosis and many treatment decisions.

For years, science-fiction moviemakers have been making us fear the bad things that artificially intelligent machines might do to their human creators. But for the next decade or two, our biggest concern is more likely to be that robots will take away our

Alice Ting's lab bustles with students working on projects relating to technologies for studying living cells in exacting molecular detail.

Three scientists discuss their pioneering discoveries about neuroplasticity, the brain's remarkable capacity to change throughout our lifetimes. For their research, Eve Marder, Michael Merzenich and Carla Shatz were named the 2016 Kavli Prize laureates in

The first research paper to describe a new phenomenon gets all the glory. A high profile publication. A great line on the scientist’s CV. Another step toward tenure.
What about the paper that verifies or fails to verify the phenomenon? That researcher ra

The 2016 Kavli Prize laureates discuss the brain's remarkable capacity for change and how that is causing us to rethink human potential.

The early stages of Alzheimer disease is marked by the wholesale destruction of synapses — junctions where neurons relay impulses from one cell to the next. As the condition progresses, whole nerve cells and even entire nerve circuits in the brain start t

Morphine and similar drugs are the world’s most widely used painkillers. But they’re also dangerous and addictive. A new compound may be able to safely provide the same analgesia as morphine.

In what might be reassuring news to many of us, psychologist Kalanit Grill-Spector, PhD, and research associate Kevin Weiner, PhD, have found evidence of our brain’s resilience.

In a Q&A, the neuroscientist discusses the reasons for continued basic and clinical research on an illegal drug scientists call 3,4-methylenedioxymethamphetamine, or MDMA, and partiers call Ecstasy.

Stanford bioengineer, neuroscientist and practicing psychiatrist Karl Deisseroth, MD, PhD, heads a huge, prolific laboratory but also oversees a program he set up years ago to train researchers from all over the world in the use of optogenetics.

The psychiatrist and bioengineer is being honored for his groundbreaking work in creating a viable technique for installing light-driven “on” and “off” switches on the surfaces of nerve cells, enabling investigators to learn exactly what they do.

Stanford molecular bioengineer Alex Savtchenko, PhD, has devised a newfangled nanoparticle whose center is a small ball of gold. It may turn out to be an effective and safer drug for Alzheimer’s version of the disease.

A recent study, and its response, heralds a new level of self-scrutiny for this area.

With big pharma short on solutions, we talk to people pioneering new ways to beat conditions including anxiety, depression and schizophrenia.